Sep 22, 2015 - The biotech sector was hit hard by Hillary Clinton's tweet about skyrocketing drug prices and her intention to come up with a plan.
Sep 22, 2015 - Dennis Lockhart’s willingness to raise rates this year along with gains in financial and technology shares helped benchmarks end in the green on Monday
Sep 21, 2015 - Amgen (AMGN) gets priority review for Kyprolis label expansion; response from the FDA should be out by Jan 22, 2016.
Sep 18, 2015 - Continued zero interest-rate policy of keeping the borrowing costs low has sparked concerns in investors about potential asset bubbles and inflation movements.
Sep 17, 2015 - Amgen (AMGN), to buy cardiovascular focused company, Dezima Pharma, strikes a deal with Xencor targeting areas of cancer immunotherapy and inflammation.
Sep 14, 2015 - Amgen (AMGN) is looking to gain FDA approval for a 420 mg monthly dose of Repatha to be given as a single injection.
Sep 14, 2015 - The COMP has adopted a positive opinion regarding the granting of orphan drug status to Kite's (KITE) KTE-C19 for the treatment of PMBCL and MCL.
Sep 11, 2015 - Benchmarks ended modestly higher on Thursday amid rise in oil prices and uncertainty about the timing of a rate hike
Sep 10, 2015 - The Zacks Analyst Blog Highlights: Amgen, Tetraphase, Geron, Alexion and ACADIA
Sep 09, 2015 - What will be the impact of biosimilar competition on Amgen's (AMGN) Neupogen now that Zarxio has been launched in the U.S.?